ChemPartner PharmaTech Co Ltd (300149) — Cash Flow Reinvestment Rate
ChemPartner PharmaTech Co Ltd (300149) has a Cash Flow Reinvestment Rate of 2.91x as of June 2023, reinvesting CN¥82.22 Million (capex CN¥66.62 Million plus investments CN¥-15.60 Million) from operating cash flow of CN¥28.21 Million. See cash generation quality of ChemPartner PharmaTech Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ChemPartner PharmaTech Co Ltd Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for ChemPartner PharmaTech Co Ltd across 19 annual periods. For the full cash flow conversion analysis, see ChemPartner PharmaTech Co Ltd operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for ChemPartner PharmaTech Co Ltd (2007–2025)
Year-by-year capital reinvestment analysis for ChemPartner PharmaTech Co Ltd. See ChemPartner PharmaTech Co Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.53x | CN¥101.07 Million | CN¥190.50 Million | CN¥62.47 Million | ▲ +28.5% |
| 2024 | 0.41x | CN¥69.47 Million | CN¥168.21 Million | CN¥69.25 Million | ▼ -71.9% |
| 2023 | 1.47x | CN¥221.69 Million | CN¥150.99 Million | CN¥201.29 Million | ▼ -22.9% |
| 2022 | 1.90x | CN¥499.85 Million | CN¥262.46 Million | CN¥336.20 Million | ▲ +137.9% |
| 2021 | 0.80x | CN¥302.77 Million | CN¥378.22 Million | CN¥286.00 Million | ▼ -33.3% |
| 2020 | 1.20x | CN¥412.05 Million | CN¥343.16 Million | CN¥394.03 Million | ▲ +0.3% |
| 2019 | 1.20x | CN¥257.54 Million | CN¥215.07 Million | CN¥254.23 Million | ▲ +103.7% |
| 2018 | 0.59x | CN¥142.94 Million | CN¥243.19 Million | CN¥109.88 Million | ▼ -51.5% |
| 2017 | 1.21x | CN¥76.93 Million | CN¥63.43 Million | CN¥4.21 Million | ▲ +260.8% |
| 2016 | 0.34x | CN¥23.95 Million | CN¥71.26 Million | CN¥10.45 Million | ▲ +33.6% |
| 2015 | 0.25x | CN¥25.33 Million | CN¥100.69 Million | CN¥25.33 Million | ▼ -80.5% |
| 2014 | 1.29x | CN¥76.93 Million | CN¥59.63 Million | CN¥76.93 Million | ▼ -5.4% |
| 2013 | 1.36x | CN¥63.17 Million | CN¥46.32 Million | CN¥63.17 Million | ▼ -39.9% |
| 2012 | 2.27x | CN¥124.91 Million | CN¥55.09 Million | CN¥124.91 Million | ▲ +25.6% |
| 2011 | 1.81x | CN¥21.06 Million | CN¥11.66 Million | CN¥21.06 Million | ▲ +122.6% |
| 2010 | 0.81x | CN¥16.89 Million | CN¥20.81 Million | CN¥16.89 Million | ▼ -42.8% |
| 2009 | 1.42x | CN¥18.83 Million | CN¥13.28 Million | CN¥18.83 Million | ▲ +26.4% |
| 2008 | 1.12x | CN¥24.33 Million | CN¥21.70 Million | CN¥24.33 Million | ▲ +285.7% |
| 2007 | 0.29x | CN¥6.45 Million | CN¥22.19 Million | CN¥6.45 Million | — |